Mark Tarby

Mark Tarby is the Vice President, Regulatory Affairs, for BrightInsight. Mark has over 25 years of global quality and regulatory leadership experience at leading digital health and medical device companies.

Prior to joining BrightInsight he was head of Quality and Regulatory for Capsule Technologies (formerly Qualcomm Life) where he provided global regulatory and quality strategic guidance in the digital health and patient monitoring space. He previously held global quality and regulatory leadership positions at St. Jude Medical, Philips Healthcare, CareFusion, Medtronic and Johnson & Johnson. Mark received a BS in Chemistry from the University of Akron, an MBA from Southern Methodist University and a JD degree from Concord Law School.

Posts by Mark Tarby

MedCity Influencers, BioPharma

Top 5 regulatory trends impacting Software as a Medical Device (SaMD)

As the biopharma space gets more competitive and the days of blockbuster drugs seem further in the rearview, biopharma companies are investing in digital to find new and innovative ways to differentiate themselves. These next-generation tools create more personalized experiences for patients, more information to guide clinical decision making and plenty of data for biopharma companies to use to continually improve therapies and to make a case for reimbursement.